Noble Capital Markets Initiates Cosmos Health Coverage With Outperform Rating
Noble Capital Markets initiated equity research coverage on Cosmos Health with an Outperform rating and a $1.40 price target.
Noble Capital Markets initiated equity research coverage on Cosmos Health with an Outperform rating and a $1.40 price target.